Cancer's Achilles' heel.
- Published in:
- Marketing Health Services, 2007, v. 27, n. 4, p. 9
- Publication type:
- Article
Works matching DE "MADRIGAL Pharmaceuticals Inc."
Results: 7
1
2
Deal watch: Synta and Roche collaborate on anti-inflammatory ion channel modulators.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 3, p. 184, doi. 10.1038/nrd2839
- Publication type:
- Article
3
Madrigal's Resmetirom Wins Historic FDA Approval for Noncirrhotic NASH.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
4
Madrigal's Resmetirom Wins Historic FDA Approval for Noncirrhotic NASH.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
5
Madrigal's Resmetirom Wins Historic FDA Approval for Noncirrhotic NASH.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
6
Movers.
- Published in:
- Nature, 2004, v. 428, n. 6985, p. 876, doi. 10.1038/nj6985-876c
- Publication type:
- Article
7
MASH Patients With High BMI, Weight Respond 'Slightly Better' to Higher Rezdiff ra Dose.
- Published in:
- Healio Gastroenterology, 2024, v. 10, n. 8, p. 18
- Publication type:
- Article